Plexus (NASDAQ:PLXS) Sets New 1-Year High After Strong Earnings

Plexus Corp. (NASDAQ:PLXSGet Free Report) reached a new 52-week high during trading on Thursday following a better than expected earnings announcement. The company traded as high as $194.06 and last traded at $184.1950, with a volume of 253085 shares traded. The stock had previously closed at $180.85.

The technology company reported $1.78 earnings per share for the quarter, topping analysts’ consensus estimates of $1.77 by $0.01. The firm had revenue of $1.07 billion during the quarter, compared to the consensus estimate of $1.07 billion. Plexus had a return on equity of 12.39% and a net margin of 4.28%.The firm’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.73 earnings per share. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS.

Plexus News Roundup

Here are the key news stories impacting Plexus this week:

  • Positive Sentiment: Plexus raised Q2 FY2026 EPS guidance to $1.80–$1.95 versus the Street at ~$1.63, and issued higher revenue guidance — a direct fundamental catalyst supporting a higher valuation and nearby analyst upgrades.
  • Positive Sentiment: Needham upgraded/raised its price target to $206 and reiterated a Buy rating, highlighting the stronger start to fiscal 2026 and supporting upside momentum. Needham raises PT to $206 (Benzinga)
  • Positive Sentiment: Benchmark raised its price target to $195, another vote of confidence from the sell-side that helps buoy the stock. Benchmark boosts PT to $195
  • Positive Sentiment: Company commentary and analyst notes point to program ramps and market-share gains that could drive >12% revenue growth in FY2026 — a growth trajectory that justifies multiple expansion. Seeking Alpha: >12% revenue growth potential
  • Positive Sentiment: Analyst write-ups and a Yahoo deep-dive attribute the guidance upgrade to specific program ramps and new manufacturing wins — concrete operational drivers versus one-off items. Yahoo: Q4 deep dive — program ramps
  • Positive Sentiment: Plexus reported Q1 EPS of $1.78 (beat by $0.01) and revenue up ~9.6% year-over-year — topline growth and a modest EPS beat help validate the raised guidance. Zacks: Q1 earnings beat
  • Neutral Sentiment: Some media/analyst coverage remains mixed on valuation and near-term sustainability of growth — expect debate on how much of the guidance is driven by a few large program ramps versus broad-based demand. Globe & Mail: mixed analyst opinions
  • Neutral Sentiment: Full earnings materials and the call transcript are available for investors who want line-item detail and management’s tone on sustainability of margins and program timing. Earnings call transcript (Seeking Alpha)

Analyst Upgrades and Downgrades

PLXS has been the subject of a number of research analyst reports. Benchmark upped their price target on shares of Plexus from $165.00 to $195.00 and gave the company a “buy” rating in a report on Wednesday. Weiss Ratings reiterated a “hold (c+)” rating on shares of Plexus in a research report on Thursday, January 22nd. Williams Trading set a $195.00 price objective on Plexus in a research note on Wednesday. Stifel Nicolaus boosted their price objective on Plexus from $150.00 to $200.00 and gave the stock a “hold” rating in a report on Friday. Finally, Sidoti lowered shares of Plexus from a “buy” rating to a “neutral” rating and set a $150.00 price objective for the company. in a research note on Friday, October 24th. Two investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Plexus currently has an average rating of “Hold” and a consensus target price of $189.20.

Read Our Latest Stock Analysis on PLXS

Insiders Place Their Bets

In related news, COO Oliver K. Mihm sold 2,327 shares of the business’s stock in a transaction that occurred on Tuesday, November 25th. The shares were sold at an average price of $143.18, for a total transaction of $333,179.86. Following the transaction, the chief operating officer directly owned 18,442 shares of the company’s stock, valued at approximately $2,640,525.56. The trade was a 11.20% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CAO Angelo Michael Ninivaggi, Jr. sold 1,347 shares of the business’s stock in a transaction on Wednesday, November 26th. The shares were sold at an average price of $144.93, for a total transaction of $195,220.71. Following the transaction, the chief accounting officer owned 21,544 shares in the company, valued at approximately $3,122,371.92. This represents a 5.88% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 9,674 shares of company stock valued at $1,382,876 over the last ninety days. Insiders own 1.78% of the company’s stock.

Hedge Funds Weigh In On Plexus

A number of hedge funds have recently added to or reduced their stakes in PLXS. Uncommon Cents Investing LLC lifted its stake in Plexus by 0.8% in the fourth quarter. Uncommon Cents Investing LLC now owns 9,925 shares of the technology company’s stock valued at $1,459,000 after acquiring an additional 75 shares during the last quarter. Congress Asset Management Co. lifted its stake in shares of Plexus by 0.5% in the 3rd quarter. Congress Asset Management Co. now owns 16,245 shares of the technology company’s stock valued at $2,350,000 after purchasing an additional 88 shares during the last quarter. Choreo LLC boosted its holdings in Plexus by 1.9% in the fourth quarter. Choreo LLC now owns 5,131 shares of the technology company’s stock worth $767,000 after purchasing an additional 94 shares in the last quarter. Huntington National Bank increased its position in Plexus by 41.5% during the second quarter. Huntington National Bank now owns 324 shares of the technology company’s stock worth $44,000 after buying an additional 95 shares during the last quarter. Finally, Nisa Investment Advisors LLC raised its holdings in Plexus by 0.8% during the third quarter. Nisa Investment Advisors LLC now owns 12,879 shares of the technology company’s stock valued at $1,863,000 after buying an additional 99 shares in the last quarter. Institutional investors and hedge funds own 94.45% of the company’s stock.

Plexus Stock Up 0.9%

The company has a market cap of $5.33 billion, a price-to-earnings ratio of 31.00 and a beta of 0.81. The business has a 50-day simple moving average of $159.97 and a two-hundred day simple moving average of $145.86. The company has a quick ratio of 0.77, a current ratio of 1.59 and a debt-to-equity ratio of 0.06.

Plexus Company Profile

(Get Free Report)

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.

Further Reading

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.